Internal Medicine · Brooklyn, NY
NPI
1023028354
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
2153 E 3rd St
Brooklyn, NY, 11223
Phone (718) 339-4607
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.1M
48,992 services
Medicare patients, 2024
1,417
Average age 76
Drug cost, 2024
$3.9M
36,044 prescriptions
Company payments, 2025
$435
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Victor Fariwa was code 99213 (office e&m - established), 10,394 times for 1,360 patients. In total Victor Fariwa billed 48,992 services in 62 codes, and Medicare paid $1.1M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 10,394 | 1,360 | $73.32 | $762K |
| J1885 Injection, ketorolac tromethamine, per 15 mg | Office | 9,480 | 612 | $0.54 | $5,148 |
| 96372 Injection Administration | Office | 8,942 | 862 | $11.82 | $106K |
| J0696 Injection, ceftriaxone sodium, per 250 mg | Office | 4,551 | 358 | $0.36 | $1,631 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2,691 | 483 | $0.77 | $2,084 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2,146 | 542 | $0.98 | $2,101 |
| 36415 Venipuncture Blood Collection | Office | 1,762 | 708 | $8.65 | $15K |
| 87804 Immunoassay | Office | 1,183 | 436 | $16.22 | $19K |
| 99212 Office E&M - Established | Office | 1,065 | 433 | $45.61 | $49K |
| 87426 Immunoassay | Office | 941 | 579 | $34.62 | $33K |
| 81002 Clinical Chemistry | Office | 857 | 389 | $3.41 | $2,922 |
| 87880 Immunoassay | Office | 840 | 550 | $16.20 | $14K |
| J0690 Injection, cefazolin sodium, 500 mg | Office | 700 | 197 | $0.64 | $445 |
| J1940 Injection, furosemide, up to 20 mg | Office | 616 | 303 | $0.38 | $237 |
| J7030 Infusion, normal saline solution , 1000 cc | Office | 556 | 262 | $2.07 | $1,149 |
By year: 2022 $1.6M for 35,596 services; 2023 $1.1M for 43,202 services; 2024 $1.1M for 48,992 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 1,762 | 708 | $8.65 | $15K |
| 87804 Immunoassay | 1,183 | 436 | $16.22 | $19K |
| 87426 Immunoassay | 941 | 579 | $34.62 | $33K |
| 81002 Clinical Chemistry | 857 | 389 | $3.41 | $2,922 |
| 87880 Immunoassay | 840 | 550 | $16.20 | $14K |
| 82947 Clinical Chemistry | 483 | 164 | $3.85 | $1,860 |
| 87807 Immunoassay | 162 | 135 | $12.84 | $2,080 |
Medicare prescription drug claims, 2024
In 2024, the drug Victor Fariwa prescribed most often to Medicare patients was Prednisone, with 855 prescriptions and refills. In total Victor Fariwa wrote 36,044 Medicare prescriptions that cost $3.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 855 | 877 | 542 | $1,485 |
| Metoprolol Succinate Generic | 768 | 1,225 | 143 | $9,091 |
| Metformin Hcl Generic | 751 | 1,057 | 137 | $2,945 |
| Rosuvastatin Calcium Generic | 749 | 1,183 | 173 | $5,797 |
| Azithromycin Generic | 732 | 732 | 490 | $2,297 |
| Diclofenac Sodium Generic | 696 | 730 | 273 | $295K |
| Cefdinir Generic | 673 | 673 | 469 | $10K |
| Amlodipine Besylate Generic | 656 | 1,075 | 136 | $2,525 |
| Tamsulosin Hcl Generic | 653 | 964 | 149 | $6,305 |
| Famotidine Generic | 637 | 697 | 293 | $7,603 |
| Atorvastatin Calcium Generic | 634 | 1,067 | 121 | $3,898 |
| Levothyroxine Sodium Generic | 632 | 969 | 126 | $3,800 |
| Pantoprazole Sodium Generic | 631 | 812 | 225 | $6,362 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 617 | 628 | 319 | $16K |
| Furosemide Generic | 614 | 748 | 202 | $1,501 |
Brand drugs: 5,542 claims; generic drugs: 30,273 claims; opioid claims: 451.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Victor Fariwa $435 ($435 in general payments such as food, travel and fees) from 10 companies. The largest payer was Heartflow, Inc. with $169.
| Company | Payments | Amount |
|---|---|---|
| Heartflow, Inc. HTFL | 8 | $169 |
| Novo Nordisk Inc NVO | 3 | $68.78 |
| Sumitomo Pharma America, Inc. 4506.T | 2 | $50.36 |
| GlaxoSmithKline, LLC. GSK | 1 | $31.79 |
| Paratek Pharmaceuticals, Inc. | 1 | $23.9 |
| E.R. Squibb & Sons, L.L.C. BMY | 1 | $22.3 |
| Almatica Pharma LLC | 1 | $18.15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $17.42 |
| Scpharmaceuticals Inc. SCPH | 1 | $16.81 |
| Abbvie Inc. ABBV | 1 | $16.19 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.